Onderneming Philadelphia Pharmaceuticals Company
Aandelen
PHIL
JO4121911013
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,36 JOD | -1,45% | 0,00% | -4,90% |
Vakgebied
Aantal werknemers: 133
Verkoop per activiteit
JOD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals for Human, Medical Supplies, Antiseptic for Dialysis, Disinfectants and X-ray Products
100,0
%
| 8 | 100,0 % | 8 | 100,0 % | -0,12% |
Verkoop per regio
JOD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Jordan
100,0
%
| 8 | 100,0 % | 8 | 100,0 % | -0,12% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ashraf Hussein
CEO | Chief Executive Officer | 42 | 01-01-13 |
Rima Shanoudeh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Director/Board Member | 62 | 01-01-13 | |
Director/Board Member | 59 | 01-09-16 | |
Belal Salameh
AUD | Comptroller/Controller/Auditor | 48 | 01-01-02 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Munther Hussein
CHM | Chairman | 56 | - |
Director/Board Member | 59 | 01-09-16 | |
Director/Board Member | 62 | 01-01-13 | |
Ahmad Syan
BRD | Director/Board Member | 55 | - |
Director/Board Member | 64 | - | |
Mohamed Syan
BRD | Director/Board Member | 56 | - |
Ashraf Hussein
CEO | Chief Executive Officer | 42 | 01-01-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 7 500 000 | 570 600 ( 7,608 %) | 0 | 7,608 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,90% | 14,39 mln. | |
+22,35% | 44,12 mld. | |
+22,22% | 22,61 mld. | |
+17,85% | 15,11 mld. | |
+15,73% | 13,61 mld. | |
+57,91% | 13,34 mld. | |
-8,98% | 6,94 mld. | |
-0,05% | 6,79 mld. | |
+15,65% | 5,75 mld. | |
-8,87% | 5,73 mld. |
- Beurs
- Aandelen
- Koers PHIL
- Onderneming Philadelphia Pharmaceuticals Company